Franklin Berger
Franklin Berger
companies few hand highly market past sensitive stocks volatile
There was overreaction, but at the same hand there probably was an overreaction to the genomics companies over the past few months. These are very highly volatile stocks ... they are very, very sensitive to the stock market itself, and also to news.
keeps last playing stage
This is very disappointing. This is the last stage of development of the drug. We're really playing for keeps at this level.
commercial further
The further you are from a commercial product, the riskier it is.